| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42f352cc5bd193c17ffff15bf60e16f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be944a7839fc8cabe752928d03dafaa4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2003-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45ee54e850a819e368d6d9c52dad8417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72c85195e4c9d66afe5e531ae4fd4699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fb9cabf769eac3d5c658a558d4ffd86 |
| publicationDate |
2006-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1683807-A1 |
| titleOfInvention |
Combination products for use in antitumoral treatment, comprising an antibody capable of inhibiting the activity of CSF-1 |
| abstract |
The present invention relates to combination products comprising (i) at least one substance capable of inhibiting the activity of CSF-1 and / or at least one nucleic acid, comprising at least one sequence coding for a substance capable of inhibiting the CSF-1 activity and (ii) at least one substance having cytotoxic activity and / or at least one nucleic acid, comprising at least one sequence coding for a substance having a cytotoxic activity. The present invention also relates to oligonucleotides capable of inhibiting the expression of CSF-1. The present invention is particularly useful in the context of the implementation of antitumor treatment. |
| priorityDate |
2002-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |